Oligometastases and oligo-recurrence: The new era of cancer therapy

Japanese Journal of Clinical Oncology

Volumn 40, Issue 2, 2010, Pages 107-111

  Niibe, Yuzuru ^a   Hayakawa, Kazushige ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Local therapy; Oligo recurrence; Oligometastases; Paradigm shift; Systemic therapy

Indexed keywords

ANTINEOPLASTIC AGENT;

BONE CANCER; BRAIN TUMOR; CANCER CLASSIFICATION; CANCER CONTROL; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; DISEASE EXACERBATION; DRUG EFFICACY; DRUG TARGETING; HUMAN; LUNG TUMOR; LYMPH NODE METASTASIS; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; OLIGOMETASTASIS; OVERALL SURVIVAL; PROGNOSIS; RADIATION DOSE; RADIOFREQUENCY ABLATION; RECURRENT CANCER; REVIEW; STEREOTACTIC RADIOSURGERY; SURVIVAL RATE; SURVIVAL TIME; MULTIMODALITY CANCER THERAPY; NEOPLASM; PATHOPHYSIOLOGY; RECURRENT DISEASE;

COMBINED MODALITY THERAPY; HUMANS; NEOPLASM METASTASIS; NEOPLASM STAGING; NEOPLASMS; RECURRENCE;

EID: 77449085961     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyp167     Document Type: Review

References (27)

1. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol 1995;13:8-10.
2. Niibe Y, Kazumoto T, Toita T, Yamazaki H, Higuchi K, Ii N, et al. Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study. Gynecol Oncol 2006;103:435-8.
3. Niibe Y, Kenjo M, Kazumoto T, Michimoto K, Takayama M, Yamauchi C, et al. Multi-institutional study of radiation therapy for isolated para-aortic lymph node recurrence in uterine cervical carcinoma: 84 subjects of a population of more than 5000. Int J Radiat Oncol Biol Phys 2006;66:1366-9.
4. Niibe Y, Kuranami M, Matsunaga K, Takaya M, Kakita S, Hara T, et al. Value of high-dose radiation therapy for isolated osseous metastasis in breast cancer in terms of oligo-recurrence. Anticancer Res 2008;28:3929-31.
5. Punglia RS, Morrow M, Winer EP, Harris JR. Local therapy and survival in breast cancer. N Engl J Med 2007;356:2399-405.
6. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997;37:745-51.
7. Kocher M, Maarouf M, Bendel M, Voges J, Muller RP, Sturm V. Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis. Strahlenther Onkol 2004;180:263-7.
8. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomized trial. Lancet 2004;363:1665-72.
9. Niibe Y, Karasawa K, Nankamura O, Shinoura N, Okamoto K, Ymada R, et al. Survival benefit of stereotactic radiosurgery for metastatic brain tumors in patients with controlled primary lesions and no other distant metastases. Anticancer Res 2003;23:4157-60.
10. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International Registry of Lung Metastases. J Thorac Cardiovasc Surg 1997;113:37-49.
11. Onihsi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007;2:S94-S100.
12. Bloomgren H, Lax I, Naslund I, Vanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995;34:861-70.
13. Uematsu M, Shioda A, Tahara K, Fukui T, Yamamoto F, Tsumatori G, et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer 1998;82:1062-70.
14. Nagata Y, Negoro Y, Aoki T, Mizowaki T, Takayama K, Kokubo M, et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2002;15:1041-6.
15. Norihisa Y, Nagata Y, Takayama K, Matsuo Y, Sakamoto T, Sakamoto M, et al. Stereotactic body radiotherapy for oligometastatic lung tumors. Int J Radiat Oncol Biol Phys 2008;72:398-403.
16. Rusthoven KE, Kavanagh BD, Burri SH, Chen C, Cardenes H, Chidel MA, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2009;27:1579-84.
17. Blomgren H, Lax I, Goranson H, Kræpelien T, Nilsson B, Näslund I, et al. Radiosurgery for tumors in the body: clinical experience using a new method. J Radiosurg 1998;1:63-74.
18. Herfarthe KK, Debus J, Lohr F, Bahner ML, Rhein B, Fritz P. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 2001;19:170. 164.
19. Kavanagh BD, Shefter TE, Cardenes HR, Stieber VW, Raben D, Timmerman RB, et al. Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol 2006;45:848-55.
20. Mendez Romero A, Wuderink W, Hussain SM, De Pooter JA, Heijmen BJ, Nowak PC, et al. Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase I-II study. Acta Oncol 2006;45:831-7.
21. Rusthoven KE, Kavanagh BD, Candenes H, Stieber VW, Burri SH, Feigenberg SJ, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009;27:1572-8.
22. Milano MT, Zhang H, Metcalfe SK, Muhs AG, Okunieff P. Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy. Breast Cancer Res Treat 2009;115:601-8.
23. Robert JK, Henry JN, Edward W. Tumors of the cervix. In: Bethesda MD, editor. Atlas of tumor pathology. Washington, DC: Armed Forces Institute of Pathology 1992;37-139.
24. Hong JH, Tsai CS, Lai CH, Chang TC, Wang CC, Chou HH, et al. Recurrent squamous cell carcinoma of the cervix after definitive radiotherapy. Int J Radiat Oncol Biol Phys 2004;60:249-57.
25. Kim JS, Kim JS, Kim SY, Kim KH, Cho MJ. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2003;55:1247-53.
26. Niibe Y, Nakano T, Ohno T, Suzuki Y, Oka K, Tsujii H. Prognostic significance of c-erbB-2/HER2 expression in advanced uterine cervical carcinoma with para-aortic lymph node metastasis treated with radiation therapy. Int J Gynecol Cancer 2003;13:849-55.
27. Choi CW, Cho CK, Yoo SY, Kim MS, Yang KM, Yoo HJ, et al. Image-guided stereotactic body radiation therapy in patients with isolated para-aortic lymph node metastases from uterine cervical and corpus cancer. Int J Radiat Oncol Biol Phys 2009;74:147-53.